Effects of radiation on growth of two human tumour cell lines surviving a previous high dose, low dose-rate, radionuclide exposureSEGERSTRÖM, Lova; STENERLOW, Bo; ERIKSSON, Veronika et al.International journal of oncology. 2008, Vol 33, Num 2, pp 341-349, issn 1019-6439, 9 p.Article

Internalisation and retention of EGF-dextran associated radioactivity in transfected chinese hamster ovary cells expressing the human EGF-receptorOLSSON, Pär; COLLINS, V. Peter; LU LIU et al.International journal of oncology. 2002, Vol 20, Num 5, pp 1057-1063, issn 1019-6439Article

Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastasesGARDMARK, Truls; WESTER, Kenneth; DE LA TORRE, Manuel et al.BJU international (Papier). 2005, Vol 95, Num 7, pp 982-986, issn 1464-4096, 5 p.Article

Targeting against epidermal growth factor receptors. cellular processing of astatinated EGF after binding to cultured carcinoma cellsORLOVA, Anna; SJÖSTRÖM, Anna; LEBEDA, Ondrej et al.Anticancer research. 2004, Vol 24, Num 6, pp 4035-4041, issn 0250-7005, 7 p.Article

The influence of lipophilicity on binding of boronated DNA-intercalating compounds in human glioma spheroidsGEDDA, Lars; GHANEOLHOSSEINI, Hadi; NILSSON, Per et al.Anti-cancer drug design. 2000, Vol 15, Num 4, pp 277-286, issn 0266-9536Article

EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastasesQICHUN WEI; LIRONG CHEN; LIMING SHENG et al.International journal of oncology. 2007, Vol 31, Num 3, pp 493-499, issn 1019-6439, 7 p.Article

Radionuclide therapy of HER2-positive microxenografts using a ¹⁷⁷Lu-labeled HER2-specific affibody moleculeTOLMACHEV, Vladimir; ORLOVA, Anna; WENNBORG, Anders et al.Cancer research (Baltimore). 2007, Vol 67, Num 6, pp 2773-2782, issn 0008-5472, 10 p.Article

Radiation therapy dose deliveryJOHANSSON, Karl-Axel; MATTSSON, Sören; BRAHME, Anders et al.Acta oncologica (Stockholm). 2003, Vol 42, Num 2, pp 85-91, issn 0284-186X, 7 p.Conference Paper

Swedish cancer society radiation therapy research investigationMATTSSON, Sören; BRAHME, Anders; STENERLÖW, Bo et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 7-8, pp 596-603, issn 0284-186X, 8 p.Article

Quantification of internalization of EGFR-binding Affibody molecules: Methodological aspectsGÖSTRING, Lovisa; CHEW, Ming Tsuey; ORLOVA, Anna et al.International journal of oncology. 2010, Vol 36, Num 4, pp 757-763, issn 1019-6439, 7 p.Article

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody moleculeFRIEDMAN, Mikaela; LINDSTRÖM, Sara; EKERLJUNG, Lina et al.Biotechnology and applied biochemistry. 2009, Vol 54, pp 121-131, issn 0885-4513, 11 p., 2Article

[¹⁷⁷Lu]Pertuzumab : Experimental therapy of HER-2-expressing xenograftsPERSSON, Mikael; GEDDA, Lars; LUNDQVIST, Hans et al.Cancer research (Baltimore). 2007, Vol 67, Num 1, pp 326-331, issn 0008-5472, 6 p.Article

A new antibody recognizing the vIII mutation of human epidermal growth factor receptorÖHMAN, Linda; GEDDA, Lars; HESSELAGER, Göran et al.Tumor biology. 2002, Vol 23, Num 2, pp 61-69, issn 1010-4283Article

Tumor imaging using a picomolar affinity HER2 binding affibody moleculeORLOVA, Anna; MAGNUSSON, Mikaela; NILSSON, Fredrik Y et al.Cancer research (Baltimore). 2006, Vol 66, Num 8, pp 4339-4348, issn 0008-5472, 10 p.Article

Ligand liposomes and boron neutron capture therapyCARLSSON, Jörgen; KULLBERG, Erika Bohl; CAPALA, Jacek et al.Journal of neuro-oncology. 2003, Vol 62, Num 1-2, pp 47-59, issn 0167-594X, 13 p.Article

Biodistribution of ²¹¹At labeled HER-2 binding affibody molecules in miceSTEFFEN, Ann-Charlott; ALMQVIST, Ylva; CHYAN, Ming-Kuan et al.Oncology reports. 2007, Vol 17, Num 5, pp 1141-1147, issn 1021-335X, 7 p.Article

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with ²¹¹At-EGFSUNDBERG, Asa Liljegren; ALMQVIST, Ylva; ORLOVA, Anna et al.European journal of nuclear medecine and molecular imaging Print. 2003, Vol 30, Num 10, pp 1348-1356, issn 1619-7070, 9 p.Article